G567-0192 Screening compound: 5-({2-[4-(2-FLUOROPHENYL)PIPERAZINO]-2-OXOETHYL}SULFANYL)-3-ISOBUTYLIMIDAZO[1,2-C]QUINAZOLIN-2(3H)-ONE

G567-0192 Screening compound: 5-({2-[4-(2-FLUOROPHENYL)PIPERAZINO]-2-OXOETHYL}SULFANYL)-3-ISOBUTYLIMIDAZO[1,2-C]QUINAZOLIN-2(3H)-ONE
G567-0192 Screening compound: 5-({2-[4-(2-FLUOROPHENYL)PIPERAZINO]-2-OXOETHYL}SULFANYL)-3-ISOBUTYLIMIDAZO[1,2-C]QUINAZOLIN-2(3H)-ONE alternative view

Chemical Structure Depiction of ChemDiv screening compound G567-0192
5-({2-[4-(2-FLUOROPHENYL)PIPERAZINO]-2-OXOETHYL}SULFANYL)-3-ISOBUTYLIMIDAZO[1,2-C]QUINAZOLIN-2(3H)-ONE

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

G567-0192

Molecular Formula

C26H28FN5O2S (C26 H28 FN5 O2 S)

Compound Name

5-({2-[4-(2-FLUOROPHENYL)PIPERAZINO]-2-OXOETHYL}SULFANYL)-3-ISOBUTYLIMIDAZO[1,2-C]QUINAZOLIN-2(3H)-ONE

IUPAC name

n/a

SMILES

CC(C)CC1N2C(SCC(N(CC3)CCN3c(cccc3)c3F)=O)=Nc(cccc3)c3C2=NC1=O

InChI

InChI=1S/C26H28FN5O2S/c1-17(2)15-22-25(34)29-24-18-7-3-5-9-20(18)28-26(32(22)24)35-16-23(33)31-13-11-30(12-14-31)21-10-6-4-8-19(21)27/h3-10,17,22H,11-16H2,1-2H3/t22-/m0/s1

InChI Key

MFNWSSMDQVFWIG-QFIPXVFZSA-N

MDL Number (MFCD)

Chemical and Physical Properties

Saltdata

n/a

Molecular Weight

493.61

Hydrogen Bond Acceptors Count

7.00

Hydrogen Bond Donors Count

0.00

Rotatable Bond Count

7.00

Number of Nitrogen and Oxygen Atoms

7

Partition Coefficient, logP

3.637

Distribution Coefficient, logD

3.637

Water Solubility, LogSw

-4.02

Polar Surface Area

54.775

Acid Dissociation Constant (pKa)

10.90

Base Dissociation Constant (pKb)

2.92

Number of Chiral Centers

1.00

Percent sp3 carbon bonding

38.50

G567-0192 in Drug Discovery

Included in Screening Libraries

CNS Targets (44014 compounds)

Adenosine Receptors Targeted Library (19896 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Nervous system
  • Cancer
  • Digestive system
  • Respiratory tract
  • Nervous system
  • Eye
  • Cardiovascular
Targets:
  • GPCR
Mechanism of action:
  • Receptor's ligands

References: we are preparing a list of scientific research reports with G567-0192 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound G567-0192?
Check Price and Availability of G567-0192, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of G567-0192 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for G567-0192
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for G567-0192
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of G567-0192 available by request